Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
December 2016

Botulinum Toxin for Borderline Personality Disorder?
In a small open-label case series, patients with borderline personality disorder benefited from botulinum toxin injections.

Lamotrigine: Brand-Name versus Generic
Two studies found no significant changes in blood levels or pharmacokinetic variables when patients with seizure disorders were switched between brand-name lamotrigine (Lamictal and others) and various generic formulations.

Drugs to Help Smokers Quit: New Data
A new study comparing varenicline (Chantix) and bupropion (Wellbutrin, Zyban, and others) with a nicotine patch and placebo in smokers with and without psychiatric diagnoses reports no significant difference in neuropsychiatric adverse events among the four treatment groups.

Antipsychotics, Pneumonia, and Alzheimer Disease
A large study in Finland found that antipsychotic use was associated with an increased risk of pneumonia both in patients with and those without Alzheimer disease.

In Brief
Children with Hypertension Score Lower on Neurocognitive Tests; Use of Hormonal Contraception in Women Linked to Depression

BTP's 40th Year
The next issue of this newsletter, January 2017, will mark the start of our 40th annual volume.

CME 2016
Please be sure to submit the Continuing Medical Education (CME) posttest and evaluation for 2016. You can complete the test online or print it out and then submit by email or fax.

Copyright Permission

Authorization to photocopy items once only solely for internal or personal use is granted provided that the base fee of $5.00 per copy plus $.05 per page is paid directly to:

Copyright Clearance Center
27 Congress St.
Salem, MA 01970

Multiple copies may not be resold or distributed without written permission of the publisher.

0199-2716/00 $5.00 + $.05.

Any unauthorized reproduction constitutes a violation of federal law.